UK markets closed

Oxford BioMedica plc (OXB.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
228.50+8.50 (+3.86%)
At close: 05:06PM BST
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
119,023
139,989
142,797
87,728
Cost of revenue
64,031
70,808
60,157
41,655
Gross profit
54,992
69,181
82,640
46,073
Operating expenses
Research development
65,044
60,937
40,189
29,749
Selling general and administrative
24,582
28,223
15,152
11,262
Total operating expenses
138,659
120,739
61,707
50,936
Operating income or loss
-83,667
-51,558
20,933
-4,863
Interest expense
4,290
8,754
888
912
Income before tax
-70,936
-45,976
19,880
-6,572
Income tax expense
-750
-817
869
-327
Income from continuing operations
-70,186
-45,159
19,011
-6,245
Net income
-61,630
-39,157
19,011
-6,245
Net income available to common shareholders
-61,630
-39,157
19,011
-6,245
Basic EPS
-0.64
-0.41
0.23
-0.08
Diluted EPS
-0.64
-0.41
0.22
-0.08
Basic average shares
96,405
94,830
83,484
79,945
Diluted average shares
96,405
94,830
85,619
79,945